Slide 1

Periop. Cases on Endocrine Disorders Thomas Maniatis Dec. 16, 2010

Slide 2

Conflicts of Interest None

Slide 3

Case 65 female DM2 on glyburide 10 bid, pioglitazone 30 qd, metformin 1g bid Cataract OR Cholecystecomy Colectomy for colon CA

Slide 4

Issues to consider Patient Factors Type of diabetes Treatments: Diet, oral agents, insulin Adequacy of control: loose, optimal, tight Surgical Factors Minor, major Timing NPO starting when and lasting how long

Slide 5

Preop control and periop complications No high-quality data suggesting preop control impacts on periop complications Small study suggested that HbA1c >7% associated with increased wound infections Case-control study showed increased risk for wound infections if sugars > 11 (CABG)

Slide 6

Effects of surgery on glucose control Stress response causing increased glucose levels glucagon, epi, GH, IL-6 and TNF-alpha

Slide 7

Goals of therapy Prevent ketoacidosis Avoid marked hyper / hypo glycemias Balanced fluids/electrolytes Tight vs. loose control Varying evidence for tight control Improved outcomes in certain populations at cost of increased hypos In general, loose control is acceptable

Slide 8

Case 65 female DM2 on metformin 1 g bid, N 10-0-0-10 Cataract OR Cholecystectomy Colectomy for CA Radical Neck Dissection for neck mass

Slide 9

Case 55 male DM1 on rapid 12-14-18-0, glargine 0-0-0-20 Cataract OR Neck Biopsy under GA (day surgery) Cholecystectomy CABG for CAD

Slide 10

IV Insulin How to write a protocol preop in stable patients When to transition from IV to SC postop How to transition from IV to SC postop

Slide 11

IV Insulin Protocols vary Separate insulin/dextrose vs. combined GIK Targets: tight vs. traditional See Protocol Calculation of starting dose Baseline total daily dose/24 safety margin of 30- 50% Dextrose depends on fluid sensitivity D5 vs. D10 Monitoring, NPO, adjustments Start early to stabilize dose by OR

Slide 12

Slide 13

IV insulin Intraop Managed by anaesthesia Postop Continue drips until no longer NPO Plan transition to SC ahead of time

Slide 14

IVSC insulin transition post-op Look at baseline dose pre-op Compare with current needs and take into account stressors (infection, etc.) and PO intake Hourly dose x 24 = total daily needs if control stable and eating well (and no infection) Preferred transition to 3 injections of short- acting with meals and 1 intermediate-long acting before bed while in hospital

Slide 15

IVSC insulin transition post-op Sliding scale Traditional vs. adaptive sliding scale Monitor transition closely Modify baseline doses daily Closer to discharge, collapse regimen down to patient-appropriate protocol

Slide 16

Slide 17

Case 35 male Pituitary surgery for tumour Panhypopit. subsequently Cort. 25/12.5, thyroxin, testosterone Hernia repair Cholecystecomy Colectomy for mass

Slide 18

Case 65 female PMR on pred. 15/d Cataract Inguinal Hernia Esophageal resection for tumour

Slide 19

Case 50 male Mod-severe COPD on intermittent prednisone 4 x per year, inhaled steroids Exczema on topical steroids Cholecystectomy Pneumonectomy for tumour

Slide 20

Effects of surgery on steroid secretion Basal secretion 8-10 mg/d of cortisol Minor surgery 50 mg/d Major surgery 75-100 mg/d (up to 200 mg/d in severe stress) Timing Biggest surge is immediately post-op (reversal of anaesthesia, extubation)

Slide 21

Surgery and steroids Assess reason for steroid exposure Primary adrenal or pituitary disease vs. other Assess magnitude of exposure Dose and duration Consider further testing of axis ACTH stimulation using the 250 microg dose Uncertain meaning Need adequate time Assess surgical stress

Slide 22

Effects of steroids on adrenal axis Likely not suppressed Chronic use of < 5 mg of prednisone Any patient on any dose of steroid for < 3 weeks Likely suppressed Any patient on > 20 mg of prednisone for > 3 weeks Any patient with clinical Cushings Intermediate Everyone else!!

Slide 23

Surgery and steroids Supplement limited to immediate periop period Hydrocortisone 50-100 mg IV pre-induction of anaesthesia, then 25-50 mg IV Q8h x 3 doses, then halve dose QD to baseline dose (or d/c) Be aware of risks of steroids periop Infections Impaired wound healing

Slide 24

Thyroid disorders and surgery Poor evidence base supporting recommendations Hypothyroidism associated with intraop. hypotension in retrospective studies Mild-mod: may choose to postpone elective surgery to optimize Severe: only emergency surgery, give T4 and T3 urgently Risk for myxedema coma Hyperthyroidism Beta blockers to control HR Thionamides Risk for thyroid storm

Slide 25

Pheochromocytoma and surgery Medical preparation focuses on avoiding hypertensive crises Alpha blockade starting 7-10 days preop phenoxybenzamine Followed by beta blockade 2-3 days preop Alternatives: Ca-channel blockers, metyrosine